Training supports multi-site clinical trial of MDMA-assisted Massed Prolonged Exposure Therapy for PTSD in active-duty service ...
A company focused on developing novel treatments for mental health this week announced that it has submitted an application to the U.S. Food and Drug Administration seeking the approval of ...
Dr. Rothbaum, known for her groundbreaking research innovating evidence-based PTSD treatments since 1986, pioneered Prolonged Exposure Therapy (PE) and Massed Prolonged Exposure Therapy (MPE). These ...
Do you feel haunted by past experiences? Are anxiety, depression, or intrusive thoughts constantly disrupting your peace? Do you struggle with strained relationships, feeling disconnected and ...
When I started MAPS in 1986, the FDA was still blocking all research with psychedelics. MAPS had to try, though we might never succeed, to gather sufficient data about the safety and efficacy of ...
Cory Jones of Healing Maps told Benzinga’s Javier Hasse at the inaugural Benzinga Psychedelics Capital Conference on Tuesday that research underway at such institutions as Johns Hopkins University and ...
If approved for medical use, the Drug Enforcement Administration would be required to reschedule the drug. MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback